ABSTRACT: The aim of this study was to evaluate the role of ageing on variability of airflow obstruction and on the specific pattern of nocturnal exacerbations ("morning dipping" of peak expiratory flow (PEF)) in asthma.
In bronchial asthma, the degree of airflow limitation is variable and this variability correlates with the degree of airway responsiveness to bronchoconstrictor stimuli [1] . A particular aspect of this variability is nocturnal asthma. In fact, nocturnal sleep is associated with manifold events and conditions that may induce or facilitate the exacerbation of airway inflammation and obstruction, including: circadian oscillations in the balance of autonomic control of the airways (with increased vagal tone); changes in hormonal levels (with decreased plasma concentrations of epinephrine and cortisol); airway cooling; and exposure to bedding allergens [2] . Therefore, the occurrence of breathlessness, wheezing and cough at night is reported, at least occasionally, by the vast majority of patients [3] .
The degree of bronchial hyperresponsiveness is reported to increase with ageing [4] . In addition, some of the factors promoting or facilitating nocturnal attacks (including oscillations in the balance of autonomic control of airway smooth muscle and ventilatory adaptations to resistive load) may undergo changes with ageing. However, the importance of circadian changes in airflow in the aged is not known, since objective assessment of the phenomenon by self-measurement of peak expiratory flow (PEF) rate is not yet a common practice in the older age group.
This study, carried out in stable asthmatics of different ages but with a comparable degree of dysfunction, was aimed at evaluating the role of ageing on the general phenomenon of variability of airflow obstruction and on the specific pattern of nocturnal exacerbation, as expressed by "morning dipping" of PEF.
Subjects and methods
The investigation was carried out on patients attending an out-patient asthma clinic. Two groups of asthmatic adults of different age were investigated: the younger group (Group A) included 23 patients aged 14-47 yrs (mean age 35 yrs); the older group (Group B) included 20 patients aged 53-74 yrs (mean age 60 yrs). Table 1 presents their mean anthropometric and clinical characteristics, including: atopic status (expressed in terms of positive response to skin tests); personal history of asthma of >5 yrs (early onset) or ≤5 yrs (late onset); and Table 1 . -Characteristics of the groups studied Pts Age Sex Atopy Time Therapy of onset n yrs M/F +/-EO LO β 2 IS AC Th medications. All patients were lifelong nonsmokers and free from comorbid conditions; none of them was under treatment with hypnotics, sedatives, or any other kind of drugs able to interfere with the perception of symptoms or the performance of measurements.
Subjects were selected on the basis of the following common criteria: diagnosis of chronic asthma, defined according to American Thoracic Society (ATS) criteria [5] ; and stable conditions as expressed by no hospital admission or change in therapeutic regimen in the preceding 3 months.
Subjects were also selected in order that the two groups did not statistically differ according to the following criteria: duration of disease; degree of functional derangement (expressed by forced expiratory volume in one second (FEV1) in % of predicted) under baseline conditions; and degree of response to treatment over the examined period (∆FEV1), expressed as the ratio of maximum attainable FEV1 over baseline FEV1 per cent.
After providing written informed consent, patients were submitted to spirometry under baseline conditions and 30 min after inhalation of a bronchodilator by metered aerosol (salbutamol 200 µg). Spirometry was always performed before lunch time, several hours after waking.
Patients were then instructed to record PEF by means of a portable meter (mini-Wright peak flow meter; Clement Clarke Ltd, London, UK). In all cases a careful educational activity on this topic (or reinforcement in cases already familiar with the technique) was provided. The quality of performance was verified at the end of a 2 week period; no difference between groups was noticed in this regard. Measurements were performed four times daily (including early, at the time of getting up in the morning, and late, at the time of going to bed in the evening). PEF was always measured in the standing position in triplicate, and the highest value recorded on a diary chart.
On the same chart, the patients recorded separately daytime and night-time asthma symptoms (cough, shortness of breath and wheeze, by responding to specific questions), as well as the use of short-acting β 2 -agonists as rescue medication.
For each patient, the following PEF indices were calculated over 24 h periods, and then averaged over a 2 week observation period: 1) amplitude of variation, corresponding to: maximum value -minimum value % 1 / 2 (maximum value -minimum value)
2) "morning dip" corresponding to: maximum value -minimum value % evening value Results were expressed as mean±standard deviation. Statistical comparisons between groups were performed by Student's t-test for unpaired data. A p-value equal to or less than 0.05 was regarded as significant. Correlations were evaluated by simple and multiple linear regression analysis. The significance of difference between slopes was checked by the analysis of covariance (ANCOVA).
Finally, the frequency distributions of patterns were evaluated by the Chi-squared method [6] .
Results
According to the selection criteria, the groups did not differ for duration of disease (13±11 yrs in Group A versus 14±12 yrs in Group B), and baseline FEV1 (71±25 versus 68±24 % pred, respectively). Similarly, no statistically significant difference was found between groups as concerned the degree of response to treatment, in terms of change of FEV1 with respect to baseline level (∆FEV1 139±60 versus 139±65 % baseline, respectively), and functional levels attainable after treatment, in terms of FEV1 % pred (89±24 versus 83±17 % pred, respectively) ( fig. 1 ). Finally, groups did not differ from the point of view of atopic status and distribution between early and late onset.
In both groups, the amplitude of variation and the degree of morning dipping showed an obvious correlation, since the two indices do not represent fully independent variables ( fig. 2 ): however, the r 2 value was 0.382 in Group A (p<0.002) and 0.846 in Group B (p<0.0001), and the slopes were statistically different (p<0.05). 
Amplitude of variation
The amplitude of variation was significantly higher in the older age group (18±8% in Group A versus 35± 26% in Group B; p<0.005) ( fig. 3a) . Conversely, in both groups, no significant difference was observed between early-onset and late-onset subjects.
The index was not correlated with age or duration of disease or the degree of reversibility within the single groups; however, when data from both groups were pooled, a significant positive correlation with age was found (p<0.03). The amplitude showed a significant negative correlation with baseline FEV1 (% pred) in both groups (p<0.01); however, the slope of the relationship was steeper in the older group, the difference between slopes being statistically significant (ANCOVA, p<0.001) (fig. 4) . When age, duration of disease and degree of reversibility were added to baseline FEV1 as independent variables in a multiple regression, the correlation with amplitude was significant in the older group only; however, r 2 increased in both groups (in Group A from 0.190 for simple regression with FEV1, to 0.289 for multiple regression; in Group B from 0.411 to 0.460).
Morning dip
The degree of morning fall in PEF differed significantly in the two groups: its mean value over 2 weeks was 10±7% in Group A and 22±17% in Group B (p< 0.005) ( fig. 3b) . Conversely, in both groups the earlyonset cases did not differ significantly from the lateonset ones.
For the simple regression analysis on pooled data of the two groups, age correlated with the degree of dipping (p<0.03); conversely, within the younger group the index was not correlated to age, duration of disease, baseline FEV1 or degree of functional reversibility. In the older group, morning dip was inversely correlated to baseline FEV1 (r 2 =0.335; p<0.01) and reversibility (r 2 = 0.199; p<0.05), but not to age or duration of disease. The multiple regression analysis (where age, duration, baseline FEV1 and reversibility were used as independent variables, and morning dip as the dependent variable) did not show a significant result in Group A; conversely, in Group B the p-value approached statistical significance (0.055), with an increase in r 2 (0.44) with respect to the simple regression model.
The number of "dippers" (defined as cases whose mean morning dip was equal to, or exceeded, a threshold value of 15%) was 5 out of 23 in Group A, as compared to 13 out of 20 in Group B, the difference being Open symbols refer to the self-reported account of nocturnal symptoms; closed symbols indicate lack of subjective awareness. All subjects from Group A with mean morning dip >15% reported nocturnal symptoms, while only 6 out of 13 subjects from Group B had subjective awareness of such symptoms.
significant (Chi-squared, p<0.005). However, nocturnal symptoms were reported by all of the five Group A "dippers", but in only 6 of the 13 Group B "dippers" (Chi-squared, p<0.04); the group lacking subjective awareness included the cases with the most pronounced functional deterioration ( fig. 5 ).
Discussion
The results of the present study indicate that in adult asthmatics, ageing is associated with an increased variability of airway calibre. As a consequence, independent of the duration of disease and the overall degree of airway dysfunction, as shown by spirometry and reversibility test, a more prominent circadian variability is shown by older patients. This difference cannot be attributed to any recognizable disease characteristic: in fact, the two groups under investigation did not show any significant difference in terms of average severity, medications, atopic status, or early onset. In particular, from the comparison within groups between patients with a history of early onset and those with late onset, no significant difference in variability of PEF was found.
The increased variability of PEF is paralleled by a higher frequency and degree of morning dipping. This was expected, as the amplitude of variation and morning dipping are not independent variables. However, the two parameters are not fully superimposable, as in asthmatics the degree of airway patency is not only under the influence of nocturnal factors, but it may change markedly over daytime hours due to entirely different factors (outdoor environment, physical activity, emotional factors, etc.). In a recent paper, D'ALONZO et al. [7] demonstrated that measurements of PEF twice daily (e.g. morning and evening) may grossly underestimate the circadian variability of PEF. This was confirmed in the present series, where the amplitude of variation (calculated over four values daily) was higher than the corresponding morning dip in all cases. In addition, the data indicate that ageing may affect the two parameters to a different extent, as suggested by the different r and slope values of their correlation recorded in the two age groups.
Variability of airway obstruction
An increased intra-individual variability of PEF is commonly assumed to be related to instability of bronchomotor tone; as such, it is considered to be a reliable indicator of bronchial hyperresponsiveness, particularly suitable for epidemiological studies [8] . For this reason, International Guidelines on the management of asthma include PEF variability among the parameters suitable for assessment of the severity of the disease [9] .
As concerns older subjects, very few investigations have applied the technique of PEF monitoring to this specific setting, and no study on the diagnostic power of PEF in elderly asthmatics has been published so far. In investigations carried out on random population samples, variability has been found to increase with age in the range 18-73 yrs [8] and 20-70 yrs [10] . However, in a recent study on healthy volunteers aged 4-84 yrs, data concerning intra-individual variability in the subset aged over 65 yrs (29 subjects) showed coefficients of variation (2.7% in males and 2.0% in females) not far from the mean value of the general adult population of the same study (2.1%) [11] .
In the present investigation, the significant correlation of variability with baseline FEV1 in both groups confirms previous observations carried out by BAHOUS et al. [12] in young adults with mild airway hyperresponsiveness. Since variability of PEF is an index of bronchial lability, the correlation cited may be interpreted as an effect of airway geometry, in fact, it may be assumed to represent an application of the general concept that the narrower the baseline calibre the higher the percentage response to bronchoconstrictive stimuli, airway resistance being inversely proportional to the fourth power of radius. Interestingly, the slope of the regression line was much steeper in the elderly, the difference being statistically significant, in other words, for an equal level of airway dysfunction, the variability of airway calibre over the day is increased in older patients. This suggests that the airways may become more twitchy with ageing. This finding is in agreement with the observations of HOPP et al. [4] , who demonstrated that in healthy subjects aged over 60 yrs airway responsiveness to methacholine increases with age.
An important factor possibly contributing to this agerelated increase in airway responsiveness is the mechanical interdependence between airways and parenchymal structures, as suggested by the results of NAGASE et al. [13] in an experimental model of ageing rats. In fact, the loss of lung elastic recoil associated with ageing [14] may reduce the effects of parenchymal attachments in preventing an excessive airway narrowing; in addition, ageing may be associated with a change in stiffness of the airway wall. The question is open and warrants further structural and functional studies.
Nocturnal asthma
The degree of morning fall in PEF has been demonstrated to represent a reliable quantitative estimate of nocturnal exacerbation of airflow obstruction [15] . In the present study, we observed a higher frequency and magnitude of morning dipping in older patients; this finding may be interpreted, in part, as an expression of the age-related increase in reactivity [4] . However, as previously emphasized, factors promoting overall circadian variability may be more numerous and heterogeneous than those producing the functional deterioration at night. This is confirmed by the different result of the multiple regression analysis with age, duration of disease, baseline FEV1 and degree of reversibility as independent variables. In fact, as concerns younger patients, morning dipping, whatever its severity, cannot be explained by these time-related and function-related variables, as demonstrated by the very low r 2 value (0.057). Conversely, in the older age group, where some nocturnal exacerbation of airway obstruction affected the majority of patients, the degree of dipping correlated both with the baseline function and the degree of reversibility. In addition, the inclusion of age and duration of disease in the panel of functional indices in a multiple regression model, resulted in a p-value approaching statistical significance, with nearly half of the variance accounted for by the selected independent variables. These results, as opposed to those relevant to younger subjects, indicate that the host of factors influencing the parameters investigated may change with ageing.
As mentioned above, some imbalance in the mechanisms of autonomic control of airway smooth muscle activity is certainly involved in the pathogenesis of nocturnal attacks. In this context, the role of the parasympathetic nervous system in determining the normal circadian variations of airway calibre [16] , as well as the pathogenesis of nocturnal asthma [17] [18] [19] , is clearly established. In this perspective, ageing may be expected to have a modulating role. In fact, the process of normal ageing is accompanied by changes in the relative contribution of excitatory and inhibitory afferents to bronchial smooth muscle, with an overall loss of sensitivity affecting, to a proportionally greater extent, the adrenergic component [20] . On this basis, the hypothesis of an agerelated dysfunction of β 2 -adrenoceptor has been proposed [21] ; the consequences may be particularly evident at night, since a nocturnal decrease in the number and affinity of these receptors has been reported in asthmatics [22] .
Another clinically relevant finding of the present study is the lack of awareness of nocturnal deterioration of airway function noticed in the majority of elderly patients showing a definite morning dip of PEF, at variance with observations in the younger age sample. This result is in agreement with previous evidence concerning the reduced perception of load in the elderly. In fact, TACK et al. [23] observed a blunted sensitivity to added inspiratory and expiratory loads in healthy subjects over 60 yrs of age, in spite of a preserved force-generating capability during breathing; This reduction in sensitivity has since been confirmed with respect both to mechanical [24] and chemical loads [25, 26] . The explanation of this phenomenon is still under debate, but may reflect changes in central integration of afferent signals, rather than a defect in the perception of loads [27] . In addition, it must be noted that the elderly are particularly prone to comorbid conditions that may further attenuate the perception of load. Among them, diabetes mellitus is particularly important because of its prevalence. O'DONNELL et al. [28] have demonstrated that patients with insulin-dependent diabetes may have an impaired ability to perceive inspiratory-resistive loads.
This condition results in a better tolerance to breathlessness for any given level of obstruction and, possibly, in a less affected quality of life. However, it implies two negative consequences: firstly, it impairs the ability to react to increased load; and secondly, it limits the adaptive changes aimed at preserving the ventilation. As concerns the former, the increased threshold for the perception of respiratory sensations may lead to a delayed recognition of the exacerbation of airway obstruction; this, in turn, would delay the self-administration of bronchodilator medications or the search for medical advice. This is particularly true during nocturnal sleep, which by itself attenuates all of the responses to respiratory stimuli. In a previous study we demonstrated that significant increase in pulmonary resistance may occur during uninterrupted nocturnal sleep, leading to spontaneous remission without awakening [29] . For this reason, as observed in the present study, the patients, and in particular the elderly, may be unaware of the nocturnal event; consequently, accounts based on self-report may substantially underestimate the prevalence and severity of the phenomenon. As a consequence, during nocturnal attacks, elderly asthmatics would be at a particularly high risk of deterioration of airway function.
The other risk of reduced sensitivity is connected with a reduced capacity to adopt strategies aimed at preserving minute ventilation. It has been demonstrated that patients showing a blunted perception of dyspnoea are predisposed to a higher risk of fatal asthma attacks [30] . This may be particularly dangerous in the setting of nocturnal asthma, since it has been demonstrated that during nocturnal attacks ventilatory adaptation to increased resistive loads is highly variable among patients, and that a subset of patients shows an ineffective strategy of adjustment of ventilatory timing and muscular output [31] .
In conclusion, in consideration of the age-related increasing frequency of nocturnal exacerbations and the higher risks associated with these events, the practice of peak expiratory flow measurement aimed at monitoring airway obstruction is highly recommended in older asthmatics.
